Migraine medication attributes important for patient compliance: concerns about side effects may delay treatment
Mercado, A., Broumand, V., Zandi-Nejad, K., Enck, A
These compounded drugs are mandated to use solely ingredients from FDA-licensed sources and undergo rigorous testing for potency, sterility, and purity
Cagrilintide is an investigational amylin analog peptide developed to complement GLP-1 receptor agonists like semaglutide and tirzepatide
Alternative repletion strategies have focused on oral administration of GSH precursors (e.g., cysteine and glycine supplementation 9 ), and intravenous administration of GSH, 10 which although promising, is invasive and inconvenient, and therefore unlikely to be a practical solution